Variant report
Variant | nsv825503 |
---|---|
Chromosome Location | chr10:90521185-90522269 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs374782630 | chr10:90521199-90521200 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs368215454 | chr10:90521221-90521222 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs372594059 | chr10:90521240-90521241 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs374553115 | chr10:90521275-90521276 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs368757108 | chr10:90521293-90521294 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs564037447 | chr10:90521327-90521328 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs560908903 | chr10:90521333-90521334 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs11202845 | chr10:90521352-90521353 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs530040659 | chr10:90521384-90521385 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187343373 | chr10:90521395-90521396 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541700950 | chr10:90521439-90521440 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs147173963 | chr10:90521476-90521477 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs548837614 | chr10:90521504-90521505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs76565247 | chr10:90521508-90521509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs199961943 | chr10:90521509-90521510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs61854001 | chr10:90521512-90521513 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs200398534 | chr10:90521513-90521514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12258975 | chr10:90521516-90521517 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs75394851 | chr10:90521519-90521520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs443591 | chr10:90521520-90521521 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs55811851 | chr10:90521524-90521525 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs61854002 | chr10:90521528-90521529 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs548599036 | chr10:90521533-90521534 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12268129 | chr10:90521536-90521537 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs147830303 | chr10:90521537-90521538 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs398114613 | chr10:90521540-90521541 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs12258979 | chr10:90521544-90521545 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10580567 | chr10:90521548-90521549 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs398014387 | chr10:90521552-90521553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192287545 | chr10:90521596-90521597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs548762410 | chr10:90521598-90521599 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs303466 | chr10:90521616-90521617 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs149849988 | chr10:90521630-90521631 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs182636873 | chr10:90521705-90521706 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs570463957 | chr10:90521721-90521722 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534705468 | chr10:90521727-90521728 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs553133753 | chr10:90521739-90521740 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368675125 | chr10:90521742-90521743 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs145900622 | chr10:90521764-90521765 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs367705347 | chr10:90521866-90521867 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs373842564 | chr10:90521899-90521900 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs371251002 | chr10:90521901-90521902 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs374684191 | chr10:90521924-90521925 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs368990506 | chr10:90521938-90521939 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs111790732 | chr10:90521946-90521947 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs575526609 | chr10:90521965-90521966 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs200581107 | chr10:90521971-90521972 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs187594634 | chr10:90521982-90521983 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs369592436 | chr10:90521994-90521995 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs373749667 | chr10:90522009-90522010 | Enhancers Weak transcription Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Lung cancer | 18438408 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Usher syndrome | 20538994 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Paraganglioma | 17535989 | CNVD |
Submicroscopic aberration syndrome | 21292638 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Colorectal cancer | 18645599 | CNVD |
Polyposis syndrome | 18645599 | CNVD |
Prostate cancer | 17245344 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 22032731 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
Cancer | 20164919 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neurocytoma | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Basal-like breast cancer | 18066063 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Prostate cancer | 21147910 | CNVD |
Lung cancer | 21911935 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 22048815 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Cervical cancer | 21062161 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 24453001 | CNVD |
Breast cancer | 16608533 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:90514600-90523200 | Weak transcription | NHEK | skin |
2 | chr10:90514800-90523400 | Weak transcription | Hela-S3 | cervix |
3 | chr10:90515000-90523200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr10:90519000-90521400 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
5 | chr10:90519400-90523400 | Weak transcription | Adipose Nuclei | Adipose |
6 | chr10:90521000-90521600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
7 | chr10:90521000-90522000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
8 | chr10:90521400-90521600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
9 | chr10:90521600-90522200 | Genic enhancers | Monocytes-CD14+_RO01746 | blood |
10 | chr10:90521600-90525200 | Genic enhancers | Primary neutrophils fromperipheralblood | blood |
11 | chr10:90522000-90522600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr10:90522000-90523000 | Strong transcription | Primary monocytes fromperipheralblood | blood |
13 | chr10:90522000-90524400 | Enhancers | GM12878-XiMat | blood |
14 | chr10:90522200-90522400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr10:90522200-90523200 | Strong transcription | Monocytes-CD14+_RO01746 | blood |